Chesnara (LON:CSN – Free Report) had its price objective increased by Berenberg Bank from GBX 373 to GBX 404 in a research report report published on Friday morning, Marketbeat reports. The firm currently has a buy rating on the stock.
Separately, Royal Bank Of Canada decreased their price objective on shares of Chesnara from GBX 370 to GBX 360 and set an “outperform” rating on the stock in a research report on Wednesday, April 15th. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Chesnara presently has an average rating of “Buy” and a consensus target price of GBX 382.
Get Our Latest Research Report on Chesnara
Chesnara Stock Performance
Insider Buying and Selling
In other Chesnara news, insider Tom Howard sold 55,544 shares of the firm’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of GBX 319, for a total transaction of £177,185.36. 0.82% of the stock is currently owned by corporate insiders.
Chesnara Company Profile
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.
Further Reading
- Five stocks we like better than Chesnara
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with MarketBeat.com's FREE daily email newsletter.
